190 related articles for article (PubMed ID: 37061917)
1. AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Penfold L; Woods A; Pollard AE; Arizanova J; Pascual-Navarro E; Muckett PJ; Dore MH; Montoya A; Whilding C; Fets L; Mokochinski J; Constantin TA; Varela-Carver A; Leach DA; Bevan CL; Nikitin AY; Hall Z; Carling D
Cell Rep; 2023 Apr; 42(4):112396. PubMed ID: 37061917
[TBL] [Abstract][Full Text] [Related]
2. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
3. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
[TBL] [Abstract][Full Text] [Related]
4. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
5. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
6. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
Penfold L; Woods A; Muckett P; Nikitin AY; Kent TR; Zhang S; Graham R; Pollard A; Carling D
Cancer Res; 2018 Dec; 78(24):6747-6761. PubMed ID: 30242113
[TBL] [Abstract][Full Text] [Related]
7. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
8. Sensing and responding to energetic stress: The role of the AMPK-PGC1α-NRF1 axis in control of mitochondrial biogenesis in fish.
Bremer K; Kocha KM; Snider T; Moyes CD
Comp Biochem Physiol B Biochem Mol Biol; 2016 Sep; 199():4-12. PubMed ID: 26393435
[TBL] [Abstract][Full Text] [Related]
9. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
11. An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK.
Kim TH; Eom JS; Lee CG; Yang YM; Lee YS; Kim SG
Br J Pharmacol; 2013 Apr; 168(7):1647-61. PubMed ID: 23145499
[TBL] [Abstract][Full Text] [Related]
12. Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers.
Kasper P; Breuer S; Hoffmann T; Vohlen C; Janoschek R; Schmitz L; Appel S; Fink G; Hünseler C; Quaas A; Demir M; Lang S; Steffen HM; Martin A; Schramm C; Bürger M; Mahabir E; Goeser T; Dötsch J; Hucklenbruch-Rother E; Bae-Gartz I
Cells; 2021 May; 10(5):. PubMed ID: 34069390
[TBL] [Abstract][Full Text] [Related]
13. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
Zadra G; Photopoulos C; Tyekucheva S; Heidari P; Weng QP; Fedele G; Liu H; Scaglia N; Priolo C; Sicinska E; Mahmood U; Signoretti S; Birnberg N; Loda M
EMBO Mol Med; 2014 Apr; 6(4):519-38. PubMed ID: 24497570
[TBL] [Abstract][Full Text] [Related]
14. Shikonin Attenuates Hepatic Steatosis by Enhancing Beta Oxidation and Energy Expenditure via AMPK Activation.
Gwon SY; Ahn J; Jung CH; Moon B; Ha TY
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316687
[TBL] [Abstract][Full Text] [Related]
15. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
Torrano V; Valcarcel-Jimenez L; Cortazar AR; Liu X; Urosevic J; Castillo-Martin M; Fernández-Ruiz S; Morciano G; Caro-Maldonado A; Guiu M; Zúñiga-García P; Graupera M; Bellmunt A; Pandya P; Lorente M; Martín-Martín N; Sutherland JD; Sanchez-Mosquera P; Bozal-Basterra L; Zabala-Letona A; Arruabarrena-Aristorena A; Berenguer A; Embade N; Ugalde-Olano A; Lacasa-Viscasillas I; Loizaga-Iriarte A; Unda-Urzaiz M; Schultz N; Aransay AM; Sanz-Moreno V; Barrio R; Velasco G; Pinton P; Cordon-Cardo C; Locasale JW; Gomis RR; Carracedo A
Nat Cell Biol; 2016 Jun; 18(6):645-656. PubMed ID: 27214280
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase regulates cancer cell growth and metabolism via nuclear and mitochondria events.
Jiang S; Wang Y; Luo L; Shi F; Zou J; Lin H; Ying Y; Luo Y; Zhan Z; Liu P; Zhu B; Huang D; Luo Z
J Cell Mol Med; 2019 Jun; 23(6):3951-3961. PubMed ID: 30993829
[TBL] [Abstract][Full Text] [Related]
17. Inorganic nitrate and nitrite ameliorate kidney fibrosis by restoring lipid metabolism via dual regulation of AMP-activated protein kinase and the AKT-PGC1α pathway.
Li X; Zhuge Z; Carvalho LRRA; Braga VA; Lucena RB; Li S; Schiffer TA; Han H; Weitzberg E; Lundberg JO; Carlström M
Redox Biol; 2022 May; 51():102266. PubMed ID: 35217293
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer.
Zheng K; Chen S; Hu X
Curr Cancer Drug Targets; 2022; 22(7):541-559. PubMed ID: 35362394
[TBL] [Abstract][Full Text] [Related]
20. New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK.
Zadra G; Priolo C; Patnaik A; Loda M
Clin Cancer Res; 2010 Jul; 16(13):3322-8. PubMed ID: 20423984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
